$THC
TENET HEALTHCARE CORP Stock $thc

$thc Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000007031822000041 Filed on July 29, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue	$4.801B	$4.638B	$4.856B
YoY Change	-1.9%	-6.38%	-1.2%
Cost Of Revenue	$817.0M	$811.0M	$838.0M
YoY Change	-1.21%	-5.59%	1.7%
Gross Profit	$3.984B	$3.827B	$4.018B
YoY Change	-2.04%	-6.54%	-1.78%
Gross Profit Margin	82.98%	82.51%	82.74%
Selling, General & Admin	$2.230B	$2.126B	$2.188B
YoY Change	0.95%	-6.75%	-1.66%
% of Gross Profit	55.97%	55.55%	54.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$209.0M	$216.0M	$201.0M
YoY Change	0.0%	-2.26%	-13.73%
% of Gross Profit	5.25%	5.64%	5.0%
Operating Expenses	$3.457B	$3.348B	$3.418B
YoY Change	-0.35%	-5.82%	-3.15%
Operating Profit	$527.0M	$553.0M	$600.0M
YoY Change	-48.03%	-5.63%	6.76%
Interest Expense	-$171.0M	$222.0M	-$144.0M
YoY Change	-175.33%	-5.53%	-18.18%
% of Operating Profit	-32.45%	40.14%	-24.0%
Other Income/Expense, Net	$6.000M	$0.00	-$2.000M
YoY Change	-14.29%	-100.0%	0.0%
Pretax Income	$380.0M	$265.0M	$528.0M
YoY Change	-50.9%	-16.93%	-21.89%
Income Tax	$112.0M	$86.00M	$108.0M
% Of Pretax Income	29.47%	32.45%	20.45%
Net Earnings	$131.0M	$179.0M	$249.0M
YoY Change	-77.34%	-30.35%	-54.4%
Net Earnings / Revenue	2.73%	3.86%	5.13%
Basic Earnings Per Share	$1.21	$0.35
Diluted Earnings Per Share	$1.192M	$0.35	$2.287M
COMMON SHARES
Basic Shares Outstanding	107.9M shares	107.8M shares	107.1M shares
Diluted Shares Outstanding	109.9M shares	108.8M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.208B	$1.351B	$2.364B
YoY Change	-47.29%	-38.42%	-3.35%
Cash & Equivalents	$1.208B	$1.351B	$2.364B
Short-Term Investments
Other Short-Term Assets	$1.566B	$1.468B	$1.557B
YoY Change	4.75%	5.76%	3.59%
Inventory	$394.0M	$387.0M	$384.0M
Prepaid Expenses	$358.0M	$349.0M	$252.0M
Receivables	$2.826B	$2.840B	$2.770B
Other Receivables	$4.000M	$18.00M	$0.00
Total Short-Term Assets	$5.998B	$6.064B	$7.075B
YoY Change	-13.14%	-18.24%	-1.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.291B	$6.259B	$6.427B
YoY Change	2.09%	1.51%	-3.96%
Goodwill	$9.979B	$9.479B	$9.261B
YoY Change	15.2%	9.47%	5.14%
Intangibles	$1.441B	$1.462B	$1.497B
YoY Change	-2.64%	-3.94%	-6.44%
Long-Term Investments	$3.312B	$3.297B	$1.806B
YoY Change	29.17%	30.57%	76.37%
Other Assets	$55.00M	$60.00M	$65.00M
YoY Change	-60.71%	-78.26%	-80.0%
Total Long-Term Assets	$21.08B	$20.56B	$20.50B
YoY Change	10.89%	7.36%	2.73%
TOTAL ASSETS
Total Short-Term Assets	$5.998B	$6.064B	$7.075B
Total Long-Term Assets	$21.08B	$20.56B	$20.50B
Total Assets	$27.08B	$26.62B	$27.58B
YoY Change	4.49%	0.21%	1.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.240B	$1.083B	$1.300B
YoY Change	12.73%	-0.09%	7.71%
Accrued Expenses	$1.030B	$1.032B	$1.099B
YoY Change	-22.73%	-12.1%	-7.65%
Deferred Revenue	$111.0M	$474.0M	$959.0M
YoY Change	-90.89%	-55.07%	45.52%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$131.0M	$125.0M	$135.0M
YoY Change	4.8%	-1.57%	-6.9%
Total Short-Term Liabilities	$4.276B	$4.368B	$5.109B
YoY Change	-20.51%	-13.86%	5.41%
LONG-TERM LIABILITIES
Long-Term Debt	$14.96B	$14.95B	$15.51B
YoY Change	6.8%	-0.95%	-0.4%
Other Long-Term Liabilities	$3.028B	$1.824B	$1.439B
YoY Change	90.2%	15.52%	-11.01%
Total Long-Term Liabilities	$17.99B	$1.824B	$1.439B
YoY Change	1030.03%	15.52%	-11.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.276B	$4.368B	$5.109B
Total Long-Term Liabilities	$17.99B	$1.824B	$1.439B
Total Liabilities	$25.84B	$22.51B	$23.32B
YoY Change	16.24%	-3.65%	-3.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$905.0M	-$1.036B	-$1.214B
YoY Change	-38.14%	-45.82%	-42.95%
Common Stock	$8.000M	$8.000M	$8.000M
YoY Change	0.0%	0.0%	14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.235B	$1.087B	$1.028B
YoY Change
Total Liabilities & Shareholders Equity	$27.08B	$26.62B	$27.58B
YoY Change	4.49%	0.21%	1.75%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	$131.0M	$179.0M	$249.0M
YoY Change	-77.34%	-30.35%	-54.4%
Depreciation, Depletion And Amortization	$209.0M	$216.0M	$201.0M
YoY Change	0.0%	-2.26%	-13.73%
Cash From Operating Activities	$315.0M	$119.0M	$357.0M
YoY Change	-27.08%	-51.43%	-19.96%
INVESTING ACTIVITIES
Capital Expenditures	-$165.0M	$152.0M	-$304.0M
YoY Change	-248.65%	24.59%	83.13%
Acquisitions
YoY Change
Other Investing Activities	-$137.0M	$12.00M	-$1.212B
YoY Change	-112.36%	-83.33%	16.99%
Cash From Investing Activities	-$302.0M	-$140.0M	-$1.516B
YoY Change	-130.29%	180.0%	26.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-156.0M	-33.00M	1.231B
YoY Change	-88.28%	-76.76%	-1356.12%
NET CHANGE
Cash From Operating Activities	315.0M	119.0M	357.0M
Cash From Investing Activities	-302.0M	-140.0M	-1.516B
Cash From Financing Activities	-156.0M	-33.00M	1.231B
Net Change In Cash	-143.0M	-54.00M	72.00M
YoY Change	-245.92%	-201.89%	-108.43%
FREE CASH FLOW
Cash From Operating Activities	$315.0M	$119.0M	$357.0M
Capital Expenditures	-$165.0M	$152.0M	-$304.0M
Free Cash Flow	$480.0M	-$33.00M	$661.0M
YoY Change	49.53%	-126.83%	8.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000070318
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-7293
	dei	Entity Registrant Name EntityRegistrantName	TENET HEALTHCARE CORP
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-2557091
	dei	Entity Address Address Line1 EntityAddressAddressLine1	14201 Dallas Parkway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75254
	dei	City Area Code CityAreaCode	469
	dei	Local Phone Number LocalPhoneNumber	893-2200
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107888705	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1351000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2364000000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2840000000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2770000000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	387000000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	384000000	usd
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	18000000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1468000000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1557000000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	6064000000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7075000000	usd
CY2022Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	3297000000	usd
CY2021Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	3254000000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	60000000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	65000000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	6172000000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5960000000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6259000000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6427000000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	9479000000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	9261000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1389000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1374000000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1462000000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1497000000	usd
CY2022Q2	us-gaap	Assets Assets	26621000000	usd
CY2021Q4	us-gaap	Assets Assets	27579000000	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	125000000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	135000000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1083000000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1300000000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	811000000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	896000000	usd
CY2022Q2	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	272000000	usd
CY2021Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	254000000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	221000000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	203000000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	474000000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	959000000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1382000000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1362000000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4368000000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5109000000	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14947000000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15511000000	usd
CY2022Q2	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	789000000	usd
CY2021Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	791000000	usd
CY2022Q2	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	407000000	usd
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	421000000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	161000000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	36000000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	14000000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	15000000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1824000000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1439000000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	22510000000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	23322000000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9735000000	usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1997000000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2203000000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	156160385	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155520691	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	8000000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	8000000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4756000000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4877000000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-231000000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-233000000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1036000000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1214000000	usd
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48330239	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48331649	shares
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2410000000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2410000000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1087000000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1028000000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	1027000000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1026000000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2114000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2054000000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26621000000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27579000000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4638000000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4954000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9383000000	usd
CY2022Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	94000000	usd
CY2021Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	19000000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	100000000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	50000000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	54000000	usd
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	54000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	100000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	96000000	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2126000000	usd
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2280000000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4308000000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4481000000	usd
CY2022Q2	us-gaap	Supplies Expense SuppliesExpense	811000000	usd
CY2021Q2	us-gaap	Supplies Expense SuppliesExpense	859000000	usd
	us-gaap	Supplies Expense SuppliesExpense	1596000000	usd
	us-gaap	Supplies Expense SuppliesExpense	1663000000	usd
CY2022Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1006000000	usd
CY2021Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1054000000	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1948000000	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	2126000000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	216000000	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	221000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	419000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	445000000	usd
CY2022Q2	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	57000000	usd
CY2021Q2	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	20000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	73000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	40000000	usd
CY2022Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-18000000	usd
CY2021Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-22000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-38000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-35000000	usd
CY2022Q2	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	1000000	usd
CY2021Q2	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	15000000	usd
	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	0	usd
	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	15000000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	553000000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	586000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1201000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1106000000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	222000000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	235000000	usd
	us-gaap	Interest Expense InterestExpense	449000000	usd
	us-gaap	Interest Expense InterestExpense	475000000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-66000000	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-31000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-109000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-54000000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	265000000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	319000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	643000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	586000000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	86000000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	185000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	106000000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	179000000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	258000000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	458000000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	480000000	usd
CY2022Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	0	usd
CY2021Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-1000000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	1000000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-1000000	usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1000000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	179000000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	257000000	usd
	us-gaap	Profit Loss ProfitLoss	459000000	usd
	us-gaap	Profit Loss ProfitLoss	479000000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	141000000	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	138000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	281000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	263000000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	38000000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	119000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	178000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	216000000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	38000000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	120000000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	177000000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	217000000	usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	usd
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1000000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	38000000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	119000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	178000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	216000000	usd
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.35
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.12
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.64
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.04
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.65
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.03
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.35
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.11
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.63
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.00
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
	us-gaap	Profit Loss ProfitLoss	459000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.99
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107790000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106822000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107636000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106566000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108750000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108569000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114054000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108317000	shares
CY2022Q2	us-gaap	Profit Loss ProfitLoss	179000000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	257000000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	1000000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	0	usd
	us-gaap	Profit Loss ProfitLoss	479000000	usd
CY2022Q2	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	3000000	usd
CY2021Q2	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	3000000	usd
	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	5000000	usd
	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	6000000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1000000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-3000000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	1000000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	3000000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	3000000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	3000000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	6000000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1000000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-2000000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1000000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2000000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4000000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	181000000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	262000000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	461000000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	483000000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	141000000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	138000000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	281000000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	263000000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40000000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	124000000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	180000000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	220000000	usd
	us-gaap	Profit Loss ProfitLoss	459000000	usd
	us-gaap	Profit Loss ProfitLoss	479000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	419000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	445000000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	132000000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	48000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	34000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	73000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	40000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-38000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-35000000	usd
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	0	usd
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	15000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-109000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-54000000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-18000000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-10000000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	15000000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	17000000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	1000000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-1000000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	59000000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	22000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	74000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	101000000	usd
	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	-173000000	usd
	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	-56000000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	86000000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-25000000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-764000000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-232000000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-41000000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6000000	usd
	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	98000000	usd
	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	85000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	347000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	779000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	307000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	243000000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	66000000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	64000000	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	209000000	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	124000000	usd
	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	9000000	usd
	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	18000000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	41000000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	19000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	11000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-200000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-195000000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2744000000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2012000000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2013000000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1409000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	24000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	15000000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	310000000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	212000000	usd
	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	9000000	usd
	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	12000000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	29000000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	5000000	usd
	thc	Proceeds From Grants From Affiliates Net Of Recoupment ProceedsFromGrantsFromAffiliatesNetOfRecoupment	0	usd
	thc	Proceeds From Grants From Affiliates Net Of Recoupment ProceedsFromGrantsFromAffiliatesNetOfRecoupment	6000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-75000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-19000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1160000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-836000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1013000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-252000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2364000000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2446000000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1351000000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2194000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	416000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	486000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-140000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-34000000	usd
	thc	Number Of Hospitals Operated NumberOfHospitalsOperated	60	hospital
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022Q2	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	99000000	usd
CY2021Q2	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	5000000	usd
	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	104000000	usd
	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	36000000	usd
CY2022Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	94000000	usd
CY2021Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	19000000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	100000000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	50000000	usd
CY2022Q2	us-gaap	Deferred Revenue DeferredRevenue	8000000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	5000000	usd
CY2022Q2	thc	Contract With Customer Liability Recoupment Of Advance Payments ContractWithCustomerLiabilityRecoupmentOfAdvancePayments	281000000	usd
CY2021Q2	thc	Contract With Customer Liability Recoupment Of Advance Payments ContractWithCustomerLiabilityRecoupmentOfAdvancePayments	152000000	usd
	thc	Contract With Customer Liability Recoupment Of Advance Payments ContractWithCustomerLiabilityRecoupmentOfAdvancePayments	475000000	usd
	thc	Contract With Customer Liability Recoupment Of Advance Payments ContractWithCustomerLiabilityRecoupmentOfAdvancePayments	152000000	usd
	thc	Finance Lease Right Of Use Assets Acquired FinanceLeaseRightOfUseAssetsAcquired	29000000	usd
	thc	Finance Lease Right Of Use Assets Acquired FinanceLeaseRightOfUseAssetsAcquired	40000000	usd
	thc	Operating Lease Right Of Use Assets Acquired OperatingLeaseRightOfUseAssetsAcquired	227000000	usd
	thc	Operating Lease Right Of Use Assets Acquired OperatingLeaseRightOfUseAssetsAcquired	96000000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1351000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2364000000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	72000000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	95000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2140000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1389000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	751000000	usd
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	711000000	usd
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	711000000	usd
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2851000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1389000000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1462000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2160000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1374000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	786000000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	711000000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	711000000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2871000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1374000000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1497000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	751000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	83000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	123000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	120000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	100000000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	81000000	usd
CY2022Q2	thc	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	244000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	92000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	95000000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	349000000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	252000000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	187000000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	199000000	usd
CY2022Q2	thc	Receivables From Government Programs Other Current Asset ReceivablesFromGovernmentProgramsOtherCurrentAsset	446000000	usd
CY2021Q4	thc	Receivables From Government Programs Other Current Asset ReceivablesFromGovernmentProgramsOtherCurrentAsset	627000000	usd
CY2022Q2	thc	Guarantees Other Current Asset GuaranteesOtherCurrentAsset	99000000	usd
CY2021Q4	thc	Guarantees Other Current Asset GuaranteesOtherCurrentAsset	104000000	usd
CY2022Q2	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	329000000	usd
CY2021Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	321000000	usd
CY2021Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1000000	usd
CY2022Q2	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	58000000	usd
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	54000000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1468000000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1557000000	usd
	thc	Percentage Investee Results Reflected PercentageInvesteeResultsReflected	1
CY2022Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1000000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2000000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2000000	usd
CY2022Q2	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	155000000	usd
CY2021Q2	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	187000000	usd
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	298000000	usd
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	375000000	usd
CY2022Q2	thc	Contract With Customer Asset Percentage To Be Reclassified To Receivable Within90 Days ContractWithCustomerAssetPercentageToBeReclassifiedToReceivableWithin90Days	0.91
CY2022Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	24000000	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	23000000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6000000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	73000000	usd
	us-gaap	Restructuring Costs RestructuringCosts	61000000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	6000000	usd
	us-gaap	Business Exit Costs1 BusinessExitCosts1	22000000	usd
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	13000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	40000000	usd
	us-gaap	Restructuring Costs RestructuringCosts	34000000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1000000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5000000	usd
CY2022Q2	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	433000000	usd
CY2021Q4	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	443000000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	143000000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	151000000	usd
CY2022Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	15072000000	usd
CY2021Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	15646000000	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	125000000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	135000000	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14947000000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15511000000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34000000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2054000000	usd
CY2022Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	186000000	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	71000000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	95000000	usd
CY2022Q1	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	-8000000	usd
CY2022Q1	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	-10000000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2056000000	usd
CY2022Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	96000000	usd
CY2022Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	38000000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	9000000	usd
CY2022Q2	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	-16000000	usd
CY2022Q2	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	23000000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2114000000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	937000000	usd
CY2021Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	141000000	usd
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	61000000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1000000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	3000000	usd
CY2021Q1	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	-9000000	usd
CY2021Q1	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	12000000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1016000000	usd
CY2021Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	177000000	usd
CY2021Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	43000000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5000000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	4000000	usd
CY2021Q2	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	3000000	usd
CY2021Q2	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	15000000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1169000000	usd
CY2022Q2	thc	Insurance Of Cybersecurity Incident Adverse Pre Tax InsuranceOfCybersecurityIncidentAdversePreTax	100000000	usd
CY2022Q2	us-gaap	Insurance Recoveries InsuranceRecoveries	5000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-38000000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	102000000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	5000000	usd
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	1997000000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	2203000000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	177000000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	161000000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	265000000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	319000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	643000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	586000000	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	56000000	usd
CY2021Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	67000000	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	135000000	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	123000000	usd
CY2022Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	11000000	usd
CY2021Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	14000000	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	25000000	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	26000000	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	28000000	usd
CY2021Q2	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	28000000	usd
	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	57000000	usd
	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	53000000	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1000000	usd
CY2021Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	7000000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1000000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	7000000	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1000000	usd
CY2021Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2000000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-3000000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-3000000	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	45000000	usd
CY2021Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	77000000	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2000000	usd
CY2021Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3000000	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	7000000	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	6000000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	86000000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	185000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	106000000	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	77000000	usd
	thc	Effective Income Tax Rate Reconciliation Change Business Interest Expense Disallowance Amount EffectiveIncomeTaxRateReconciliationChangeBusinessInterestExpenseDisallowanceAmount	39000000	usd
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1000000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	35000000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	33000000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	38000000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107790000	shares
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.35
CY2022Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	960000	shares
CY2022Q2	thc	Effect Of Dilutive Securities Per Share Amount EffectOfDilutiveSecuritiesPerShareAmount	0
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	38000000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108750000	shares
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.35
CY2021Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	120000000	usd
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106822000	shares
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.12
CY2021Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1747000	shares
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	16000000	usd
CY2021Q2	thc	Effect Of Dilutive Securities Per Share Amount EffectOfDilutiveSecuritiesPerShareAmount	-0.01
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	120000000	usd
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108569000	shares
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.11
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	177000000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107636000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.64
	us-gaap	Dilutive Securities DilutiveSecurities	9000000	usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6418000	shares
	thc	Effect Of Dilutive Securities Per Share Amount EffectOfDilutiveSecuritiesPerShareAmount	-0.01
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	186000000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114054000	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.63
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	217000000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106566000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.04
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1751000	shares
	thc	Effect Of Dilutive Securities Per Share Amount EffectOfDilutiveSecuritiesPerShareAmount	-0.04
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	217000000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108317000	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.00
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	-1000000	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	1000000	usd
CY2022Q2	us-gaap	Assets Assets	26621000000	usd
CY2021Q4	us-gaap	Assets Assets	27579000000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	152000000	usd
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	122000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	307000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	243000000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4638000000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4954000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9383000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9735000000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	54000000	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	221000000	usd
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	54000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	100000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	96000000	usd
CY2022Q2	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	843000000	usd
CY2021Q2	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	834000000	usd
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1731000000	usd
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1611000000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	216000000	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	221000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	419000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	445000000	usd
CY2022Q2	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	843000000	usd
CY2021Q2	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	834000000	usd
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1731000000	usd
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1611000000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	216000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	419000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	445000000	usd
CY2022Q2	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	57000000	usd
CY2021Q2	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	20000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	73000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	40000000	usd
CY2022Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-18000000	usd
CY2021Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-22000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-38000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-35000000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	222000000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	235000000	usd
	us-gaap	Interest Expense InterestExpense	449000000	usd
	us-gaap	Interest Expense InterestExpense	475000000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-66000000	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-31000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-109000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-54000000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000000	usd
CY2022Q2	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	1000000	usd
CY2021Q2	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	15000000	usd
	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	0	usd
	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	15000000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	265000000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	319000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	643000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	586000000	usd

Files In Submission

Name	View Source	Status
0000070318-22-000041-index-headers.html	Edgar Link	pending
0000070318-22-000041-index.html	Edgar Link	pending
0000070318-22-000041.txt	Edgar Link	pending
0000070318-22-000041-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thc-20220630.htm	Edgar Link	pending
thc-20220630.xsd	Edgar Link	pending
thc-20220630ex10b.htm	Edgar Link	pending
thc-20220630ex31a.htm	Edgar Link	pending
thc-20220630ex31b.htm	Edgar Link	pending
thc-20220630ex32.htm	Edgar Link	pending
thc-20220630_cal.xml	Edgar Link	unprocessable
thc-20220630_def.xml	Edgar Link	unprocessable
thc-20220630_htm.xml	Edgar Link	completed
thc-20220630_lab.xml	Edgar Link	unprocessable
thc-20220630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THC
TENET HEALTHCARE CORP Stock $thc

2022 Q3 Form 10-Q Financial Statement

#000007031822000041 Filed on July 29, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC TENET HEALTHCARE CORP Stock $thc

2022 Q3 Form 10-Q Financial Statement

#000007031822000041 Filed on July 29, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC
TENET HEALTHCARE CORP Stock $thc